Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer

被引:62
作者
Tan, Abel H. Y. [1 ]
Tu, WenJuan [1 ]
McCuaig, Robert [1 ]
Hardy, Kristine [1 ]
Donovan, Thomasina [1 ]
Tsimbalyuk, Sofiya [2 ]
Forwood, Jade K. [2 ]
Rao, Sudha [1 ]
机构
[1] Univ Canberra, Epigenet & Transcript Lab Melanie Swan Mem Transl, Sci Tech, Canberra, ACT, Australia
[2] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia
基金
英国医学研究理事会;
关键词
macrophage polarization; LSD1; CoREST; breast cancer; epigenetics; tumor microenvironment; tumor associated macrophages; CLINICAL-FEATURES; TISSUE INHIBITOR; INFLAMMATION; DNA; ANGIOGENESIS; PLASTICITY; SIGNATURES; RESPONSES; SYSTEM; CELLS;
D O I
10.3389/fimmu.2019.01351
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages play an important role in regulating the tumor microenvironment (TME). Here we show that classical (M1) macrophage polarization reduced expression of LSD1, nuclear REST corepressor 1 (CoREST), and the zinc finger protein SNAIL. The LSD1 inhibitor phenelzine targeted both the flavin adenine dinucleotide (FAD) and CoREST binding domains of LSD1, unlike the LSD1 inhibitor GSK2879552, which only targeted the FAD domain. Phenelzine treatment reduced nuclear demethylase activity and increased transcription and expression of M1-like signatures both in vitro and in a murine triple-negative breast cancer model. Overall, the LSD1 inhibitors phenelzine and GSK2879552 are useful tools for dissecting the contribution of LSD1 demethylase activity and the nuclear LSD1-CoREST complex to switching macrophage polarization programs. These findings suggest that inhibitors must have dual FAD and CoREST targeting abilities to successfully initiate or prime macrophages toward an anti-tumor M1-like phenotype in triple-negative breast cancer.
引用
收藏
页数:17
相关论文
共 99 条
[1]   Subtyping of Triple-Negative Breast Cancer: Implications for Therapy [J].
Abramson, Vandana G. ;
Lehmann, Brian D. ;
Ballinger, Tarah J. ;
Pietenpol, Jennifer A. .
CANCER, 2015, 121 (01) :8-16
[2]  
AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817
[3]   TAMeless traitors: macrophages in cancer progression and metastasis [J].
Aras, Shweta ;
Zaidi, M. Raza .
BRITISH JOURNAL OF CANCER, 2017, 117 (11) :1583-1591
[4]   CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated Antigens [J].
Asano, Kenichi ;
Nabeyama, Ami ;
Miyake, Yasunobu ;
Qiu, Chun-Hong ;
Kurita, Ai ;
Tomura, Michio ;
Kanagawa, Osami ;
Fujii, Shin-ichiro ;
Tanaka, Masato .
IMMUNITY, 2011, 34 (01) :85-95
[5]   Epigenetic modifiers as new immunomodulatory therapies in solid tumours [J].
Aspeslagh, S. ;
Morel, D. ;
Soria, J. -C. ;
Postel-Vinay, S. .
ANNALS OF ONCOLOGY, 2018, 29 (04) :812-824
[6]   A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation [J].
Atianand, Maninjay K. ;
Hu, Wenqian ;
Satpathy, Ansuman T. ;
Shen, Ying ;
Ricci, Emiliano P. ;
Alvarez-Dominguez, Juan R. ;
Bhatta, Ankit ;
Schattgen, Stefan A. ;
McGowan, Jason D. ;
Blin, Juliana ;
Braun, Joerg E. ;
Gandhi, Pallavi ;
Moore, Melissa J. ;
Chang, Howard Y. ;
Lodish, Harvey F. ;
Caffrey, Daniel R. ;
Fitzgerald, Katherine A. .
CELL, 2016, 165 (07) :1672-1685
[7]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[8]   iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM [J].
Battye, T. Geoff G. ;
Kontogiannis, Luke ;
Johnson, Owen ;
Powell, Harold R. ;
Leslie, Andrew G. W. .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2011, 67 :271-281
[9]  
Benjamini Y, 2001, ANN STAT, V29, P1165
[10]   Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B [J].
Binda, Claudia ;
Wang, Jin ;
Li, Min ;
Hubalek, Frantisek ;
Mattevi, Andrea ;
Edmondson, Dale E. .
BIOCHEMISTRY, 2008, 47 (20) :5616-5625